SLC16A2 and nervous system disorder: It is notable that mutations in the gene for MCT8 (SLC16A2) result in impairment of TH passage through the blood–brain barrier and are associated with severe neurological diseases (i.e., Allan–Herndon–Dudley syndrome) [9].